CSPC Pharmaceutical GroupCSPCY +1.18%79 Days Inventory is 133.96 as of Dec. 2025, which is 8% above its 10-year median of 124.23. GuruFocus rates CSPCY with a GF Score™ of 79/100 and a GF Value™ of $3.31 (Fairly Valued). The stock has 4 warning signs investors should review. Among 917 Drug Manufacturers companies, CSPC Pharmaceutical Group ranks better than 68.59% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
CSPC Pharmaceutical Group's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.68.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CSPC Pharmaceutical Group's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.51.
CSPC Pharmaceutical Group (OTCPK:CSPCY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
CSPC Pharmaceutical Group's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CSPC Pharmaceutical Group's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
CSPC Pharmaceutical Group Days Inventory Related Terms
CSPC Pharmaceutical Group Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPCY vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSPC Pharmaceutical Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where CSPC Pharmaceutical Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CSPC Pharmaceutical Group (CSPCY) has a Days Inventory of 133.96 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CSPC Pharmaceutical Group and its competitors. This is near median its historical median of 124.23. Over the past decade, CSPC Pharmaceutical Group's Days Inventory has ranged from 110.89 to 170.17. According to the industry distribution chart, CSPC Pharmaceutical Group ranks #288 out of 917 companies in the Drug Manufacturers industry, placing it in the top 31.4%.
Is CSPC Pharmaceutical Group's Days Inventory too high?
CSPC Pharmaceutical Group's current Days Inventory of 133.96 is near median its 10-year median of 124.23. Over the past 10 years, this metric has ranged from a low of 110.89 to a high of 170.17. The Drug Manufacturers industry median Days Inventory is 164.48. CSPC Pharmaceutical Group's value of 133.96 is 18.6% below this industry median. Based on the distribution chart, CSPC Pharmaceutical Group ranks #288 out of 917 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, CSPC Pharmaceutical Group has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, CSPC Pharmaceutical Group ranks #288 out of 917 companies for Days Inventory. This puts CSPC Pharmaceutical Group in the upper half of its industry. The industry median Days Inventory is 164.48. CSPC Pharmaceutical Group's value of 133.96 is 18.6% below this benchmark. Historically, CSPC Pharmaceutical Group's own Days Inventory has ranged from 110.89 to 170.17 over the past decade. While the company's 10-year median is 124.23 vs. the industry median of 164.48, CSPC Pharmaceutical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 917 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CSPC Pharmaceutical Group's current Days Inventory of 133.96 is 18.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CSPC Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CSPC Pharmaceutical Group's current Days Inventory is 133.96, which is near median its own 10-year median of 124.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group (CSPCY) is currently considered Fairly Valued. The stock's GF Value™ is $3.31, compared to a current price of $3.55 — trading 7.3% above its estimated fair value. The current Days Inventory is 133.96, which is near median its 10-year median of 124.23 and 18.6% below the Drug Manufacturers industry median of 164.48. CSPC Pharmaceutical Group's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For CSPC Pharmaceutical Group (CSPCY), the current Days Inventory is 133.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CSPC Pharmaceutical Group (CSPCY) Overvalued in 2026?
Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued.
The current stock price of $3.55 is trading 7.3% above its estimated GF Value™ of $3.31.
GuruFocus considers CSPC Pharmaceutical Group to be Fairly Valued.
Key valuation signals for CSPCY:
Days Inventory: 133.96 (near median its 10-year median of 124.23)
GF Value™: $3.31 vs. price of $3.55 (7.3% above fair value)
Industry Position: 18.6% below the Drug Manufacturers median (#288 of 917)
No single metric tells the full story. See the CSPCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
79GF Score
Get the complete analysis for CSPCY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSPCY has been successfully added to your 
